Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Table 1

Baseline characteristics of patients exposed to drugs (categorical variables presented as absolute patient numbers and quantitative variables presented as mean [SD] values).

	Amisulpride	Olanzapine
Age [years]
Mean [SD]	29.1 [7.05]	31.4 [8.16]
Gender
[Male/female]	18/14	17/15
Weight [kg]	52.5 [8.78]	49.7 [9.32]
Duration of illness [weeks]	11.3 [3.22]	10.8 [3.54]
Mean BPRS score	54.7 [5.92]	57.5 [7.73]